11 results match your criteria: "is with The Ottawa Hospital[Affiliation]"
Can J Hosp Pharm
April 2024
, BSc, PharmD, ACPR, RPh, is with the London Health Sciences Centre, London, Ontario.
Background: Expansion of the scope of pharmacists' activities in hospital is associated with reductions in adverse events and drug-related readmissions. However, the breadth of hospital pharmacists' clinical activities varies widely across Ontario due to provisions in the provincial . Few data exist defining expanded scope in institutions across Ontario.
View Article and Find Full Text PDFCan J Hosp Pharm
September 2023
, BSc, BScPharm, RPh, is with Hôpital Montfort, Ottawa, Ontario.
Background: Patient safety incidents are the third leading cause of death in Canada. These occurrences have negative effects on patients and on the well-being of health care professionals. They also lead to financial burdens on the health care system.
View Article and Find Full Text PDFCan J Hosp Pharm
October 2022
, PhD, is with the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, and Simon Fraser University, Burnaby, British Columbia.
Background: Advances in treatment have turned HIV from a terminal illness to a more manageable condition. Over the past 20 years, there have been considerable changes to HIV treatment guidelines, including changes in preferred antiretrovirals and timing of initiation of combination antiretroviral therapy (cART).
Objective: To examine real-world trends in cART utilization, viral control, and immune reconstitution among people living with HIV in Canada.
Can J Hosp Pharm
January 2021
, PharmD, is with The Ottawa Hospital and the Ottawa Hospital Research Institute, Ottawa, Ontario.
Background: Vancomycin remains widely used for methicillin-resistant (MRSA) infections; however, treatment failure rates up to 50% have been reported. At the authors' institution, monitoring of trough concentration is the standard of care for therapeutic drug monitoring of vancomycin. New guidelines support use of the ratio of 24-hour area under the concentration-time curve to minimum inhibitory concentration (AUC/MIC) as the pharmacodynamic index most likely to predict outcomes in patients with MRSA-associated infections.
View Article and Find Full Text PDFCan J Hosp Pharm
July 2021
, BScPhm(Hons), ACPR, BCOP, MHM, is with the Ottawa Hospital Research Institute, and Extend Pharmacy, Ottawa, Ontario, and the School of Pharmacy, University of Waterloo, Kitchener, Ontario.
Can J Hosp Pharm
October 2020
, MD, MHA, FRCPC, is with The Ottawa Hospital, Ottawa, Ontario.
Background: Administration of chemotherapy to highly vulnerable, critically ill patients in the intensive care unit (ICU) is becoming more common, but the process requires significantly more resources than chemotherapy administration in specialized oncology settings.
Objective: To describe the context, complications, and outcomes of chemotherapy administration for cancer-related indications in ICU patients.
Methods: For this retrospective observational study, consecutive patients receiving parenteral chemotherapy in the ICU at the General Campus of The Ottawa Hospital between January 1, 2014, and December 31, 2017, were identified using pharmacy records.
Can J Hosp Pharm
June 2020
, BPharm, MSc, RPh, is with The Ottawa Hospital, Ottawa, Ontario.
Can J Hosp Pharm
March 2018
, MD, FRCPC, FACP, FIDSA, CCPE, is with Public Health Ontario and the Department of Medicine, University of Toronto, Toronto, Ontario.
Background: Antimicrobial allergy labels, either self-reported or placed in a patient's medical record, are common, but in many cases they are not associated with a true immunoglobulin E-mediated allergic response.
Objective: To assess the impact of antimicrobial allergy labels on antimicrobial prescribing, resource utilization, and clinical outcomes.
Data Sources: The MEDLINE, Embase, CINAHL, and Scopus electronic databases were searched for the period 1990 to January 2016.
Can J Hosp Pharm
September 2016
, BScPharm, ACPR, MSc(Epi), is with The Ottawa Hospital and the Ottawa Hospital Research Institute, Ottawa, Ontario.
Background: Adverse drug events (ADEs) occurring in hospital inpatients can have serious implications. The ability to identify and prioritize patients at higher risk of ADEs could help pharmacists to optimize their impact as members of the patient care team.
Objective: To identify risk factors, patient characteristics, and medications associated with a higher likelihood of ADEs in adult inpatients through an overview of reviews on this topic.
Can J Hosp Pharm
May 2015
BScPhm, ACPR, FCSHP, is with the Department of Pharmacy, The Ottawa Hospital, Ottawa, Ontario.
Background: Antimicrobial resistance due to production of extended-spectrum ß-lactamases by Escherichia coli and Klebsiella species (ESBL-EK) is concerning. Previous studies have shown that bacteremia due to ESBL-producing organisms is associated with increases in length of stay and/or mortality rate. Rates of infection by ESBL-EK vary worldwide, and regional differences in the prevalence of risk factors are likely.
View Article and Find Full Text PDFCan J Hosp Pharm
November 2014
BSc, PharmD, ACPR, is with The Ottawa Hospital Research Institute and the Pharmacy Department, The Ottawa Hospital- General Campus, Ottawa, Ontario; the Faculty of Medicine, University of Ottawa, Ottawa, Ontario; and the Faculty of Pharmacy, Université de Montréal, Montréal, Quebec.
Background: Each year, about one-third of individuals over the age of 65 years will experience a fall, and half of these will experience a subsequent fall in the following year. The use of potentially inappropriate medications (PIMs) is an important factor contributing to increased fall risk in geriatric patients.
Objective: To determine the proportion of patients over the age of 65 admitted to orthopedics and general medicine services with diagnosis of a fall who experienced a change in the total number or dosage of PIMs, as defined by the Beers criteria, upon discharge from hospital.